AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $239,000 | -97.3% | 31,900 | -96.8% | 0.00% | -97.2% |
| Q1 2022 | $9,012,000 | +317.2% | 990,324 | +439.7% | 0.04% | +227.3% |
| Q3 2020 | $2,160,000 | -82.8% | 183,512 | -78.4% | 0.01% | -86.6% |
| Q2 2020 | $12,553,000 | +129.8% | 850,504 | +110.2% | 0.08% | +86.4% |
| Q1 2020 | $5,462,000 | -79.9% | 404,590 | -71.4% | 0.04% | -73.7% |
| Q3 2019 | $27,153,000 | +117.1% | 1,412,759 | +595.3% | 0.17% | +221.2% |
| Q3 2018 | $12,506,000 | +1.6% | 203,180 | +11.5% | 0.05% | +6.1% |
| Q2 2018 | $12,314,000 | +388.3% | 182,300 | +251.3% | 0.05% | +345.5% |
| Q3 2017 | $2,522,000 | +334.1% | 51,900 | +160.8% | 0.01% | +175.0% |
| Q4 2014 | $581,000 | – | 19,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |